Publications by authors named "Peter A Lio"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

500,880

Total Likes

6,029

Extended Reach

558,654

Social Features

22
M
Myths and media in oral collagen supplementation for the skin, nails, and hair: A review.
Andrea M Rustad, Melissa A Nickles, Jenna E McKenney, Sara N Bilimoria, Peter A Lio

February 2022

Videos about Article: user user user 2

5 3 17 2 48

View All Article and Social Media Activity
P
Patient and Caregiver Perceptions on Education and Treatment Needs in Atopic Dermatitis from an International Survey.
Kristen Willard, Špela Novak, Peter A Lio, Mark Luttmann, Gretchen McCreary

Dermatol Ther (Heidelb)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lebrikizumab Improved Itch Symptoms and Reduced Itch Interference on Sleep over 52 Weeks in Patients with Moderate-to-Severe Atopic Dermatitis in Two Phase 3 Trials.
Gil Yosipovitch, Peter A Lio, David Rosmarin, Franz J Legat, Esther Serra-Baldrich

Dermatology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid clinical response to nemolizumab in dermatologic diseases associated with pruritus and burning: A multicenter case series.
Emi M Murase, Ajay S Dulai, Sammer Marzouk, Peter A Lio, Raja K Sivamani

J Am Acad Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sunscreens: Mechanisms and Safety in Depth.
Natalia V Chałupczak, Peter A Lio

J Drugs Dermatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2).
Eric Simpson, Pablo Fernández-Peñas, Marjolein de Bruin-Weller, Peter A Lio, Chia-Yu Chu

Adv Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2).
Eric Simpson, Pablo Fernández-Peñas, Marjolein de Bruin-Weller, Peter A Lio, Chia-Yu Chu

Adv Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Pharmacokinetics of Lebrikizumab in Healthy Individuals After Subcutaneous Administration Using a Prefilled Syringe or Autoinjector in a Phase 1 Randomized Study.
Amita Datta-Mannan, Brian Moser, Wen Xu, Kimberley Jackson, Jennifer Witcher, Peter A Lio

Clin Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonsteroidal Approaches for Atopic Dermatitis®: A Clinical Update.
Peter Y Ch'en, Peter A Lio

Dermatitis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the pediatric dermatologist in childhood bullying prevention and intervention: A call to action.
Kripa Raj Ahuja, Peter A Lio

Clin Dermatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving systemic therapy selection for inflammatory skin diseases: A clinical need survey.
Nicholas D Brownstone, Aaron S Farberg, Graham H Litchman, Ann P Quick, Jennifer J Siegel, Peter A Lio

JAAD Int· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mental Health Services: The Missing Piece or Missing Peace for Patients With Atopic Dermatitis.
Peter A Lio

Cutis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary and Alternative Therapies for Psoriasis.
Natalia V Chalupczak, Peter A Lio

Arch Dermatol Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis.
Peter A Lio, April Armstrong, Jan Gutermuth, Audrey Nosbaum, Howard Sofen

Dermatol Ther (Heidelb)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the clinical utility of the Atopic Dermatitis Control Tool: measurement properties and agreement between patients' responses and clinicians' impressions of atopic dermatitis control.
Eric L Simpson, Laurent Eckert, Abhijit Gadkari, T Michelle Brown, Peter A Lio

Br J Dermatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical steroids or emollients: does order matter?
Kripa Ahuja, Peter A Lio

Arch Dermatol Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Food-Triggered Atopic Dermatitis a Form of Systemic Contact Dermatitis?
Kripa Ahuja, Christopher J Issa, Susan T Nedorost, Peter A Lio

Clin Rev Allergy Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lebrikizumab improved itch and reduced the extent of itch interference on sleep in patients with moderate-to-severe atopic dermatitis: two randomized, placebo-controlled, phase III trials.
Gil Yosipovitch, Peter A Lio, David Rosmarin, Esther Serra-Baldrich, Franz J Legat

Br J Dermatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials.
Derek K Chu, Alexandro W L Chu, Daniel G Rayner, Gordon H Guyatt, Juan José Yepes-Nuñez, Peter A Lio

J Allergy Clin Immunol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials.
Alexandro W L Chu, Melanie M Wong, Daniel G Rayner, Gordon H Guyatt, Juan Pablo Díaz Martinez, Peter A Lio

J Allergy Clin Immunol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A response to "Steroid phobia on social media platforms".
Kripa Ahuja, Grace DeSena, Peter A Lio

Pediatr Dermatol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photobiomodulation therapy and low-level light therapy in wound healing.
Ishita Aggarwal, Peter A Lio

Lasers Med Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atopic Dermatitis: Beyond the Skin and Into the Gut.
Rachel L Sadowsky, Pranvera Sulejmani, Peter A Lio

J Clin Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of topically applied therapeutic ammonia oxidising bacteria in adults with mild-to-moderate atopic dermatitis and moderate-to-severe pruritus: a randomised, double-blind, placebo-controlled, dose-ranging, phase 2b trial.
Jonathan I Silverberg, Peter A Lio, Eric L Simpson, Connie Li, Daniel R Brownell

EClinicalMedicine· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Values and Preferences of Patients and Caregivers Regarding Treatment of Atopic Dermatitis (Eczema): A Systematic Review.
Keon Andre Maleki-Yazdi, Anja Fog Heen, Irene X Zhao, Gordon H Guyatt, Erica A Suzumura, Peter A Lio

JAMA Dermatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis